Cooperative Agreement IDSEP180044

Drive Therapeutics, L.L.C. was awarded a $256,000 Project Grant from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to support optimizing assembly of bispecific aptamer therapeutics. The one-year award running from September 2021 through October 2022 will fund Drive Therapeutics' work to advance science and engineering research and innovation leading to breakthrough technologies as well as solutions to national challenges, as outlined...

The Massachusetts Technology Collaborative was awarded a $3.3 million project grant from the Department of Commerce Economic Development Administration under the Economic Adjustment Assistance program (CFDA 11.307) on April 15, 2021 to develop and run two COVID-19 recovery challenges. The challenges are designed to source, accelerate, and validate potential digital health solutions that can help the economies of Massachusetts and the United States recover from COVID-19 more quickly. Lever,...

This Cooperative Agreement award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program provides $999,878 to Akttyva Therapeutics, Inc., a small business located in Watertown, MA, to develop an AI-assisted drug discovery platform to identify existing drugs and new chemical entities capable of repairing vascular permeability barriers. The project aims to address unmet clinical needs for conditions like acute respiratory distress...

This Cooperative Agreement award from the Defense Advanced Research Projects Agency (DARPA) under the Research and Technology Development program (CFDA 12.910) provides $14,997,315 to The Johns Hopkins University to test the feasibility of managing a complex polytrauma patient starting near the point of injury and continuing through the evacuation process using a single intravascular cannula that can be placed by a field medic. The performance period runs from September 2024 through March...

Rnet Technologies Inc. received a $768,283.44 Project Grant award from the National Institutes of Health's National Institute of Biomedical Imaging and Bioengineering on September 30, 2021 to develop techniques enabling next generation machine learning for large scale image analysis through March 29, 2022. Under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), Rnet will develop software to automatically map deep learning networks...

This Cooperative Agreement award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $1,000,000 in funding to Apricity Robotics Inc. to develop a tele-directed, artificially intelligent sonography robot capable of performing complete echocardiogram procedures. The key objectives of this 2-year project are to: 1) increase the throughput and efficiency of cardiac sonographers by enabling remote supervision of the data...

This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Cellecho, Inc. supports the development of a microchip-based technology that leverages sound waves and electric fields to enable advanced cell engineering. The goal is to make complex cellular modifications, such as multiplex genome editing, more accessible for a wide range of users from students to experienced researchers. The technology aims to streamline processes...

Magic Medical Solutions LLC was awarded a $649,958 Small Business Innovation Research (SBIR) Project Grant from the Department of Agriculture's National Institute of Food and Agriculture to develop the Tele Case Assessment & Response Engine ICU (TeleCARE-ICU). TeleCARE-ICU is an intelligent, mobile platform that provides comprehensive automated intensive care unit patient monitoring and assessment using machine learning algorithms. It takes inputs from standard monitoring devices, the...

The Department of the Army Medical Command awarded Cedars-Sinai Medical Center a $1,542,272 project grant under the Military Medical Research and Development program (CFDA 12.420) to develop targeted bioparticles for treating brain-metastatic breast cancer. The grant aims to advance an investigational drug delivery platform utilizing HER3-homing bioparticles (HPK BPs) loaded with corroles, a class of porphyrin-like compounds, to target brain metastases. Cedars-Sinai will modify its HPK protein...

The National Cancer Institute (NCI) awarded a $399,358 Project Grant (CFDA 93.394 - Cancer Detection and Diagnosis Research) to Cordance Medical Inc., a for-profit medical technology company in Mountain View, CA. The grant supports the development and optimization of the "NeuroAccess System", a non-invasive focused ultrasound technology that enables liquid biopsies for brain tumor patients. The key objectives of this Phase I SBIR project are to: 1) demonstrate the safety of repeated...